Wei Zhang

3PUBLICATIONS
28CO-AUTHORS
Molecular targetsGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jan 28, 2025
Design, Structure Optimization, and Preclinical Characterization of JAB-21822, a Covalent Inhibitor of KRAS<sup>G12C</sup>.

Amin Li, Sujing Li, Peng Wang

|Aug 07, 2024
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment.

Cunbo Ma, Di Kang, Panliang Gao

|May 08, 2020
Chemical perturbations reveal that RUVBL2 regulates the circadian phase in mammals.

Dapeng Ju, Wei Zhang, Jiawei Yan

Pageof 1

Frequent Collaborators

2 joint publications

Yinxiang Wang

2 joint publications

Yanping Wang

1 joint publications

Dapeng Ju

1 joint publications

Jiawei Yan

1 joint publications

Haijiao Zhao

1 joint publications

Wei Li

1 joint publications

Jiawen Wang

1 joint publications

Meimei Liao

1 joint publications

Amin Li

1 joint publications

Long Mei

Frequent Collaborators

2 joint publications

Yinxiang Wang

2 joint publications

Yanping Wang

1 joint publications

Dapeng Ju

1 joint publications

Jiawei Yan

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

13.6K
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on : Jul 17, 2020

6.2K
<em>In Vitro</em> Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells
11:56

<em>In Vitro</em> Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells

Published on : Sep 28, 2017

10.3K
See more related videos

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

13.6K
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on : Jul 17, 2020

6.2K
<em>In Vitro</em> Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells
11:56

<em>In Vitro</em> Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells

Published on : Sep 28, 2017

10.3K
See more related videos